Drug interactions
Pancuronium + Rocuronium
Severity: Moderate
Pancuronium and Rocuronium: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both are non-depolarizing neuromuscular blockers, so combining them produces additive paralysis. Prolonged or unpredictable blockade and delayed recovery may result, especially if a second agent is given before the first has worn off.
What this interaction means in plain words
Pancuronium and Rocuronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Pancuronium belongs to Musculoskeletal; Rocuronium belongs to Musculoskeletal.
Why it happens
Additive competitive antagonism at postsynaptic nicotinic acetylcholine receptors of the neuromuscular junction.
What to do
Avoid routine co-administration of two non-depolarizing blockers and use quantitative train-of-four monitoring if sequential use occurs. Adjust subsequent doses to the degree of residual blockade and ensure full recovery or reversal before extubation.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Pancuronium and Rocuronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Rocuronium
Other interactions of Pancuronium
Frequently asked questions
Can I take Pancuronium with Rocuronium?
MediHelp rates the interaction as moderate. Pancuronium and Rocuronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both are non-depolarizing neuromuscular blockers, so combining them produces additive paralysis. Prolonged or unpredictable blockade and delayed recovery may result, especially if a second agent is given before the first has worn off.
How serious is the interaction between Pancuronium and Rocuronium?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid routine co-administration of two non-depolarizing blockers and use quantitative train-of-four monitoring if sequential use occurs. Adjust subsequent doses to the degree of residual blockade and ensure full recovery or reversal before extubation.
What other medicines interact with Rocuronium?
MediHelp also lists interactions of Rocuronium with, for example, Amikacin, Bacitracin-neomycin-polymyxin, Capreomycin. The full list is on the Rocuronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
